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OBJECTIVES: To compare the estimates of Prevalence Ratio (PR) and Odds Ratios
(OR) as effect measures in the analysis of cross sectional data for obese individuals
sufferingwith chronic comorbid conditions.METHODS:Medical Expenditure Panel
Survey data files from 2005-2007 was utilized for the analysis. Obese adults were
defined as individuals with age 20 years and having a BMI 30. Prevalence ratios
were estimated from logistic regressions by dividing predicted prevalence esti-
mates of comorbidities among obese individuals to the predicted prevalence of
comorbidities in non-obese individuals after adjusting for socio-demographic fac-
tors. Ninety-five percent boot-strapped confidence intervals were generated
around the prevalence ratios. Odds ratios were generated by using the ‘Survey
Logistic’ syntax in SAS after adjusting for the same socio-demographic factors.
RESULTS: Both odds ratios and prevalence ratios indicate that obese individuals
have a greater burden of chronic conditions in the United States. Obese individuals
had the greatest odds of having hypertension and osteoarthritis followed by coro-
nary heart disease, diabetes and dyslipidemia. Prevalence ratios were highest for
diabetes, followed by hypertension, osteoarthritis and dyslipidemia. Odds ratios
were almost always greater than the prevalence ratios for all chronic conditions.
The confidence intervals derived around odds ratios were also wider than the
confidence intervals around the prevalence ratios. CONCLUSIONS: The relative
importance of obesity upon different disease conditions differed depending on
whether PR or OR were estimated. This study along with previous literature shows
that odds ratiosmay be overestimating the true effect of a disease condition on the
prevalence of a comorbid disease. Although it is easier to derive odds ratios, prev-
alence ratiosmay bemore realistic estimates of the true public health burden. Thus
prevalence ratios should ideally be used as effect measures instead of odds ratios
especially for commonly occurring disease conditions.
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OBJECTIVES:The objective of knowledge study (TOCKS)was to quantify the patient
burden and to characterize patient symptomatology and acceptance of treatment
with anakinra in Cryopyrin-associated Periodic Syndrome (CAPS), an orphan dis-
ease. Additionally, chart review and patient recall of symptoms, adverse events,
and resource use were compared. The aforementioned objectives were completed
through the use of a unique online approach to gathering data and rapidly display-
ing the results.METHODS: This retrospectivemedical chart review and concurrent
online patient survey, conducted in Centers of Excellence for CAPS in Europe, was
accomplished by analyzing data entered via internet-based case report forms
(CRFs). Data were entered into the CRFs by both study groups for two distinct
collection periods—prior to and during the most recent 12 months of anakinra
treatment. RESULTS: Four sites (50 patients total) participated in TOCKS. Prior to
entering data, users viewed an online tutorial to help in completing the survey. No
patients were lost to follow up and the data were successfully collected, analyzed,
and reviewed via the online CRF and dynamically-generated data tables. This in-
novative online approach allowed users to enter de-identified data, in multiple
sessions, even in the most remote destinations. One patient successfully com-
pleted their survey in the Amazon. In addition, a unique identifier was randomly
generated that linked chart review with patient recall data online. Site investiga-
tors were also able to view the dynamic tables and reports online and benchmark
themselves against the other, encrypted, sites. CONCLUSIONS: This novel internet
technology allowed for efficient data collection from multiple sites and multiple
sources within a short time frame. The unique identifier made it effortless to col-
lect and compare the entries from the chart and from the patients for the same
patient.
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OBJECTIVES: To compare rates of obesity-associated comorbidities between the
General Electric (GE) Centricity EMR and Thomson Reuters MedStat MarketScan
commercial claims databases in patients with either a recorded BMI 25 (GE EMR)
or ICD-9 code for overweight/obesity (MarketScan). METHODS: From the GE EMR,
subjects aged 20-64 with at least one BMI value 25 and 2 y of EMR activity prior
to BMI index date were included. FromMarketScan, subjects 20 y (mostly 65 y),
with a claim (ICD-9 code) for overweight, obesity, ormorbid obesity, and365 days
of claims activity after selected comorbidity was first recorded, were included.
Selected comorbidities were identified by ICD-9 codes in both databases and strat-
ified by BMI or overweight/obesity claims. RESULTS: In the GE EMR, 109,885 sub-
jects (36.7%) were overweight or obese (BMI 25). Of these, 51% had BMI 25-29.9,
28% had BMI 30-34.9, and 22% had BMI 35. In the MarketScan database, 246,261
subjects (0.7%) had overweight, obesity, ormorbid obesity claims. Of these, 4%were
overweight, 66% were obese, and 30% were morbidly obese. The three most prev-
alent comorbidities in both databases, across all weight categories, were hyperten-
sion, hyperlipidemia, and chronic back pain, except diabetes replaced back pain in
the morbid obesity group in MarketScan. For all comorbidities, prevalence was
higher in MarketScan, except polycystic ovary syndrome prevalence was higher in
GE EMR BMI 35 group compared to morbid obesity group in MarketScan.
CONCLUSIONS: Despite different methods (BMI vs. ICD-9 codes) for capturing obe-
sity between two databases, prevalence rankings of comorbidities were similar.
Obesity is therapeutically classified by BMI; however, most large claims databases
capture obesity by ICD-9 codes. This may result in variation in weight group dis-
tributions and significant under-reporting of obesity claims in MarketScan. Our
findings highlight the need for further research in optimal sources for data in obese
patients.
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OBJECTIVES: This study tests a flexible modeling approach, which endogenously
estimates the non-linear and asymmetric functional form for body mass index
(BMI), to examine the relationship betweenmortality and obesitymeasured as BMI
30. METHODS: This study used the National Health Interview Survey (NHIS),
between 1997 and 2000. Respondents were linked to the National Death Index with
mortality follow-up through 2005. We estimated the 5-year probability of death
using the logistic regression model adjusting for BMI, age and sex. The multivari-
able fractional polynomials (MFP) procedure was employed to determine the best
fitting functional form for BMI and compared to alternative functional forms using
a chi-squared test. Expected years of life lost due to obesity were based on adjusted
death probabilites and computed using standard life table functions.RESULTS:The
best fitting adjustment model contains the powers 1 and 2 for BMI. A chi-
squared test shows a statistically significant improvement in model fit compared
to other BMI polynomial functions. The estimated relationship between 5-year
probability of death and BMI exhibits a J-shaped pattern forwomen and aU-shaped
pattern for men. The BMI associated with minimum mortality is 27.53 for males
and 25.19 for females. A 40-year-old female with a BMI of 40 has an estimated 5.82
fewer years of expected life compared to an analogous female with a BMI of 25. For
a comparable change in BMI in a 40-year-old male, the expected years of life lost is
5.20. CONCLUSIONS: The BMI-mortality relation is flat around the minimum, but
especially highmortality is associated with themorbidly obese. TheMFP approach
provides a robust alternative to estimating mortality by allowing the data to deter-
mine the best fitting model. The approach is also useful in estimating the relation-
ship between the full spectrum of BMI values and other health outcomes.
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OBJECTIVES: The MusiQOL questionnaire was co-developed in 15 countries to as-
sess the quality of life of patientswithMultiple Sclerosis. The objective of this study
was to test the cultural relevance of the instrument in 4 Arabic countries (Egypt,
Morocco, Saudi Arabia and Tunisia) and Iran, not involved in the initial develop-
ment, and to assess the conceptual equivalence of the translations with the UK
original used as a basis for translation.METHODS: In each country, the translation
process was conducted by a linguistic expert, using either the standard forward/
backward methodology or the adjusted process (adaptation from the Saudi Arabia
version), including cognitive interviews with 6 patients. The basis for discussion
was the concept list developed in collaborationwith the author. RESULTS: Linguis-
tic and cultural issues emerged during the translation process. First, the acronym
“MS” used throughout the original version for ”Multiple Sclerosis” was replaced by
the full name in Arabic countries for clarity, but not in Iran where the patients
preferred the abbreviation. Second, using euphemistic expressions for taboo con-
cepts such as sex life proved necessary to ensure homogenous response across all
languages without any negative connotation. Finally, leisure activities (e.g. shop-
ping, going out to amovie, gardening) described in the original had to be adapted to
the religious and social context in the target countries. CONCLUSIONS: The 5 lan-
guage versions of the MusiQol were established following a proven standardized
methodology, on the basis of a concept list worked out with the author, to allow
international data pooling and mining whilst addressing the specific challenges of
regional adaptation. The process as a whole supports the advantage of integrating
continuous and diverse international feedback on wording during the linguistic
validation process.
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OBJECTIVES: The IQWiG’s method provides a concept for the drawing of an effi-
ciency limit and its extrapolation to the assessment of the cost-benefit relation.
Here benefits are to be assessed in terms of a set of clinical endpoints. PREs might
include different issues of mortality, morbidity and health-related quality of life as
well as other important factors identified as being patient-relevant. Efficiency fron-
tiers cannot be drawn for all possible outcomes, it is important to determinewhich
factors are most relevant to patients. IQWiG allows different efficiency frontiers.
How can contradictory results be interpreted? The problemwithin the utility mea-
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